Vinyl Chloride

Summary

Vinyl Chloride (CHEMBL2311071) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 62.5 Da · C2H3Cl

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL2311071
Name	Vinyl Chloride
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	6338
ChEBI	CHEBI:28509
Molecular formula	C2H3Cl
Molecular weight	62.5
InChIKey	BZHJMEDXRYGGRV-UHFFFAOYSA-N

SMILES: C=CCl

IUPAC name: chloroethene

ChEBI definition: A monohaloethene that is ethene in which one of the hydrogens has been replaced by a chloro group.

Pharmacological roles (ChEBI): carcinogenic agent.

Also known as: Ethylene chloride, F-1140, Vinyl chloride, Chloroethene, VINYL CHLORIDE

Patent coverage: 217,546 distinct patent families (527,732 SureChEMBL compound mentions), from 3 matched compound structure(s). One matched structure accounts for 527,652 (100%) of the total. Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).